Merck & Co Inc

Why weight-loss drugs are the top target of Medicare price negotiations

Michael McTague: In 2025, the pharmaceutical industry is ripe for M&A

Michael McTague: 5 key pharmaceutical trends that will carry into 2025

Swine flu is replacing COVID on pharmaceutical companies’ target list

Analyst ratings changes include AMD, Apple and MongoDB

Obesity, oncology and old age: How 2023 pharmaceutical M&A is reshaping the health-care industry

A Look at Pharma M&A — Consolidating Strengths In Oncology, Immunology and More

Big Pharma and The Need for Speed